RU2015120181A - Чресслизистая доставка токотриенола - Google Patents
Чресслизистая доставка токотриенола Download PDFInfo
- Publication number
- RU2015120181A RU2015120181A RU2015120181A RU2015120181A RU2015120181A RU 2015120181 A RU2015120181 A RU 2015120181A RU 2015120181 A RU2015120181 A RU 2015120181A RU 2015120181 A RU2015120181 A RU 2015120181A RU 2015120181 A RU2015120181 A RU 2015120181A
- Authority
- RU
- Russia
- Prior art keywords
- tocotrienol
- delivery
- pharmaceutical composition
- transmucosal
- composition according
- Prior art date
Links
- GJJVAFUKOBZPCB-UHFFFAOYSA-N 2-methyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol Chemical compound OC1=CC=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-UHFFFAOYSA-N 0.000 title claims 10
- 229930003802 tocotrienol Natural products 0.000 title claims 10
- 239000011731 tocotrienol Substances 0.000 title claims 10
- 235000019148 tocotrienols Nutrition 0.000 title claims 10
- 238000000034 method Methods 0.000 claims 13
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 5
- 229930003799 tocopherol Natural products 0.000 claims 5
- 239000011732 tocopherol Substances 0.000 claims 5
- 229960001295 tocopherol Drugs 0.000 claims 5
- 235000010384 tocopherol Nutrition 0.000 claims 5
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims 5
- 239000000203 mixture Substances 0.000 claims 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 210000003205 muscle Anatomy 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 201000004384 Alopecia Diseases 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 206010020880 Hypertrophy Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 206010028594 Myocardial fibrosis Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- 230000003111 delayed effect Effects 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 230000003676 hair loss Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 claims 1
- 150000003626 triacylglycerols Chemical class 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2012904937A AU2012904937A0 (en) | 2012-11-13 | Sublingual and buccal delivery of tocotrienol derivatives as therapeutic agents | |
| AUAU2012904937 | 2012-11-13 | ||
| AU2012905406A AU2012905406A0 (en) | 2012-12-11 | Sublingual and buccal delivery of tocotrienol derivatives as therapeutic agents | |
| AUAU2012905406 | 2012-12-11 | ||
| PCT/AU2013/001310 WO2014075135A1 (en) | 2012-11-13 | 2013-11-13 | Transmucosal delivery of tocotrienol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2015120181A true RU2015120181A (ru) | 2017-01-10 |
Family
ID=50730398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015120181A RU2015120181A (ru) | 2012-11-13 | 2013-11-13 | Чресслизистая доставка токотриенола |
Country Status (22)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9171343B1 (en) | 2012-09-11 | 2015-10-27 | Aseko, Inc. | Means and method for improved glycemic control for diabetic patients |
| US9897565B1 (en) | 2012-09-11 | 2018-02-20 | Aseko, Inc. | System and method for optimizing insulin dosages for diabetic subjects |
| PT2919777T (pt) * | 2012-11-13 | 2020-03-30 | Invictus Biotechnology Pty Ltd | Distribuição transmucosa de tocotrienol |
| US9233204B2 (en) | 2014-01-31 | 2016-01-12 | Aseko, Inc. | Insulin management |
| US9486580B2 (en) | 2014-01-31 | 2016-11-08 | Aseko, Inc. | Insulin management |
| JP6989262B2 (ja) | 2014-10-27 | 2022-01-05 | アセコー インコーポレイテッド | 皮下外来患者管理 |
| US11081226B2 (en) | 2014-10-27 | 2021-08-03 | Aseko, Inc. | Method and controller for administering recommended insulin dosages to a patient |
| WO2017025808A1 (en) * | 2015-08-11 | 2017-02-16 | Satoru Sugiyama | System and method for improved blood circulation and maintaining mitochondrial energy production |
| US9886556B2 (en) | 2015-08-20 | 2018-02-06 | Aseko, Inc. | Diabetes management therapy advisor |
| WO2019032685A1 (en) * | 2017-08-08 | 2019-02-14 | Robert John Petcavich | FORMULATIONS FOR THE CONTRIBUTION OF TREHALOSE STIMULATING AUTOPHAGIA |
| EP4255417A4 (en) * | 2020-12-04 | 2024-10-23 | Invictus Biotechnology Pty Ltd. | Transmucosal delivery of tocotrienols |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2124086A1 (en) * | 1991-11-22 | 1993-05-27 | Ronald H. Lane | Tocotrienols and tocotrienol-like compounds and methods for their use |
| JPH0892050A (ja) | 1994-09-27 | 1996-04-09 | Lion Corp | 消臭剤及び口腔用組成物 |
| JP4271742B2 (ja) | 1997-08-07 | 2009-06-03 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 免疫機能改善剤 |
| US6264981B1 (en) | 1999-10-27 | 2001-07-24 | Anesta Corporation | Oral transmucosal drug dosage using solid solution |
| JP2001342133A (ja) | 2000-03-31 | 2001-12-11 | Eisai Co Ltd | γ―トコトリエノール含有利尿剤 |
| ES2346181T3 (es) | 2000-03-31 | 2010-10-13 | EISAI R&D MANAGEMENT CO., LTD. | Uso de gamma-tocotrienol como diuretico. |
| JP2002037727A (ja) | 2000-07-26 | 2002-02-06 | Eisai Co Ltd | 脂溶性薬物を配合した速崩性固形製剤及びその製造方法 |
| JP4693140B2 (ja) | 2000-10-06 | 2011-06-01 | 富士化学工業株式会社 | トコトリエノール含有医薬用剤 |
| JP4447198B2 (ja) | 2001-02-08 | 2010-04-07 | 富士化学工業株式会社 | トコトリエノールを有効成分とする血管新生阻害剤、細胞増殖阻害剤、管腔形成阻害剤及びｆｇｆ阻害剤並びに食品或いは食品添加物 |
| US6608103B2 (en) | 2001-02-08 | 2003-08-19 | Fuji Chemical Industry Co., Ltd. | Inhibitor for neovasculation, cell multiplication, lumen formation and FGF |
| ES2391215T3 (es) | 2003-02-14 | 2012-11-22 | Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Protección contra la radiación mediante gamma tocotrienol, succinato de alfa-tocoferol o succinato de gamma-tocoferol |
| CA2521020C (en) | 2003-04-10 | 2021-04-27 | Barrie Tan | Annatto extract compositions including tocotrienols and tocopherols and methods of use |
| US20050209315A1 (en) * | 2004-03-20 | 2005-09-22 | Papas Andreas M | Bioavailable nutritional supplement and method of treatment of malabsorption |
| CA2567969A1 (en) * | 2004-05-26 | 2005-12-08 | Kgk Synergize Inc. | Compositions comprising flavonoids and tocotrienols and methods thereof |
| CN1775289B (zh) | 2004-11-15 | 2011-08-24 | 杭州赛诺菲民生健康药业有限公司 | 多维生素口腔崩解片制剂及其制备方法 |
| WO2009121039A2 (en) | 2008-03-28 | 2009-10-01 | Hale Biopharma Ventures, Llc | Administration of benzodiazepine compositions |
| WO2009126866A2 (en) | 2008-04-10 | 2009-10-15 | Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Delta-tocotrienol as a radioprotective countermeasure agent |
| EP2437730A4 (en) | 2009-05-20 | 2014-02-26 | Lingual Consegna Pty Ltd | ORAL AND / OR SUBLINGUAL THERAPEUTIC FORMULATION |
| WO2010151348A1 (en) | 2009-06-25 | 2010-12-29 | Edison Pharmaceuticals, Inc. | Treatment of pervasive developmental disorders with tocotrienols or tocotrienol enriched extracts |
| PL2470168T3 (pl) * | 2009-08-26 | 2018-06-29 | Bioelectron Technology Corporation | Sposoby zapobiegania i leczenia niedokrwienia mózgu |
| EP2519232A1 (en) | 2009-12-31 | 2012-11-07 | Edison Pharmaceuticals, Inc. | Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinones |
| EP2555765A4 (en) | 2010-04-06 | 2013-08-14 | Edison Pharmaceuticals Inc | TREATMENT OF ATAXIE TÉLANGIECTASIE |
| US20120295985A1 (en) | 2010-11-19 | 2012-11-22 | Miller Guy M | Methods for improving blood glucose control |
| KR101796340B1 (ko) | 2011-02-18 | 2017-11-10 | 바이오링거스 아이피 엘엘씨 | 안정화된 활성제를 포함하는 생성물을 제조하는 방법 및 이를 포함하는 조성물 |
| ES2683902T3 (es) | 2011-06-14 | 2018-09-28 | Hale Biopharma Ventures, Llc | Administración de benzodiacepina |
| PT2919777T (pt) * | 2012-11-13 | 2020-03-30 | Invictus Biotechnology Pty Ltd | Distribuição transmucosa de tocotrienol |
-
2013
- 2013-11-13 PT PT138544408T patent/PT2919777T/pt unknown
- 2013-11-13 PE PE2015000622A patent/PE20151518A1/es not_active Application Discontinuation
- 2013-11-13 ES ES13854440T patent/ES2778065T3/es active Active
- 2013-11-13 SG SG11201503640WA patent/SG11201503640WA/en unknown
- 2013-11-13 RU RU2015120181A patent/RU2015120181A/ru not_active Application Discontinuation
- 2013-11-13 US US14/435,607 patent/US10675265B2/en active Active
- 2013-11-13 PL PL13854440T patent/PL2919777T3/pl unknown
- 2013-11-13 CN CN202011457257.1A patent/CN112451518B/zh active Active
- 2013-11-13 CN CN201380022566.8A patent/CN104582700B/zh active Active
- 2013-11-13 DK DK13854440.8T patent/DK2919777T3/da active
- 2013-11-13 JP JP2015540965A patent/JP6460998B2/ja active Active
- 2013-11-13 NZ NZ628963A patent/NZ628963A/en unknown
- 2013-11-13 AU AU2013344817A patent/AU2013344817B2/en active Active
- 2013-11-13 MY MYPI2015000856A patent/MY177940A/en unknown
- 2013-11-13 WO PCT/AU2013/001310 patent/WO2014075135A1/en not_active Ceased
- 2013-11-13 KR KR1020147022626A patent/KR20150082109A/ko not_active Withdrawn
- 2013-11-13 CA CA2891164A patent/CA2891164C/en active Active
- 2013-11-13 BR BR112015010703-6A patent/BR112015010703B1/pt active IP Right Grant
- 2013-11-13 EP EP13854440.8A patent/EP2919777B1/en active Active
-
2015
- 2015-05-10 IL IL238727A patent/IL238727A0/en unknown
- 2015-05-11 PH PH12015501048A patent/PH12015501048A1/en unknown
- 2015-05-11 IN IN4006DEN2015 patent/IN2015DN04006A/en unknown
- 2015-06-10 ZA ZA2015/04191A patent/ZA201504191B/en unknown
-
2018
- 2018-09-21 JP JP2018177662A patent/JP6978392B2/ja active Active
-
2020
- 2020-04-23 US US15/929,297 patent/US11331302B2/en active Active
- 2020-10-09 JP JP2020171008A patent/JP2021008509A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2015120181A (ru) | Чресслизистая доставка токотриенола | |
| JP2016503407A5 (cg-RX-API-DMAC7.html) | ||
| RU2015127794A (ru) | Введение антисмысловых олигонуклеотидов, комплементарных человеческому аполипопротеину в | |
| RU2016129266A (ru) | Композиции и способы лечения и/или предотвращения сердечно-сосудистого заболевания | |
| JP2010059183A5 (cg-RX-API-DMAC7.html) | ||
| CN104592025B (zh) | 一种阿魏酸酯类化合物及其制备方法 | |
| JP2009525990A5 (cg-RX-API-DMAC7.html) | ||
| FI4349369T3 (fi) | Lääkkeen biologisen hyötyosuuden lisääminen naltreksonihoidossa | |
| RU2014129508A (ru) | Новая комбинация | |
| ES2712944T3 (es) | Composiciones de extracto de achiote, que incluyen geranilgeranioles para su uso en la reducción del nivel de triglicéridos en sangre | |
| CN104667283B (zh) | 一种治疗血脂异常和动脉粥样硬化的复方药物组合 | |
| NO20080244L (no) | Doseringsstyring for prasugrel | |
| JP2014533701A5 (cg-RX-API-DMAC7.html) | ||
| KR20100132489A (ko) | 난소암을 치료하기 위하여 파클리탁셀을 포함하는 조합 | |
| EA021395B1 (ru) | Комбинация инсулина с триазиновыми производными и их применение для лечения диабета | |
| CN103239439B (zh) | 用于治疗高血脂及动脉粥样硬化的组合物及其用途 | |
| JP2019507786A5 (cg-RX-API-DMAC7.html) | ||
| RU2017112748A (ru) | Композиции онапристона пролонгированного действия и способы | |
| RU2013105513A (ru) | Производные 1-аминоалкилциклогексана для лечения воспалительных заболеваний кожи | |
| JP2016514706A5 (cg-RX-API-DMAC7.html) | ||
| Hanada et al. | Evaluation of the effect of tranilast on rats with spinal cord injury | |
| EA022862B1 (ru) | ПРИМЕНЕНИЕ БЕНЗИДАМИНА ПРИ ЛЕЧЕНИИ p40-ЗАВИСИМЫХ ЗАБОЛЕВАНИЙ | |
| CN103690473A (zh) | 一种青藤碱制剂及其制备方法 | |
| RU2019110755A (ru) | Сублингвальное или буккальное введение dim для лечения заболеваний кожи | |
| CN107427508B (zh) | 异喹啉衍生物用于糖尿病伤口愈合的用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20180424 |